BERLIN, GERMANY — Once-weekly subcutaneous administration of emicizumab (Roche) as prophylaxis reduced or prevented bleeds in people with hemophilia A and inhibitors to factor VIII. More than half of ...
PARAMUS, N.J., July 26, 2023 – Octapharma USA today announced that Balfaxar ® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex ®) has received U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . Assessment and treatment of a bleeding episode in patients on oral anticoagulants are essential for the proper ...
The study pooled data from 4 clinical trials to gain insight into surgical outcomes in this complex population. Both major and minor surgeries are common for patients with hemophilia A, and these ...
Credit: Octapharma. Balfaxar is a human plasma-derived, purified, virus inactivated and nanofiltered non-activated prothrombin complex concentrate. Balfaxar ® (prothrombin complex concentrate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback